Eighty nine of 104 patients with hairy cell leukemia (HCL), enrolled between 1985 and 1987 in a multicenter prospective study on human lymphoblastoid IFN alpha-n1, were evaluable for long-term follow-up. The induction treatment, 3 MU/mq daily for a median of 5.7 months, produced a response of 93%, complete+partial response (CR+PR) = 80%, minor (MR) = 13%. Neither prior splenectomy nor pre-treatment variables were associated with the rate of response to IFN. However maintenance treatment of 3 MU/mq weekly given randomly had a slightly significant effect on failure free survival (FFS). Of the 43 patients who relapsed, 31/36 (86%) obtained a new response with IFN. No differences in FFS were recorded between first and second response. At the third induction 7/11 patients were treated again with IFN, 4/7 obtaining some response, but the FFS was significantly worse. The overall survival is still 85%. We conclude that (1) IFN should be used as chronic uninterrupted treatment for HCL, (2) reduced dosage is sufficient to prolong the disease free status and (3) continuous lymphoblastoid IFN administration seems not to be associated with the development of resistance to retreatment.

Long term results of interferon treatment in hairy cell leukemia / Capnist, G.; Federico, Massimo; Chisesi, T.; Resegotti, L.; Lamparelli, T.; Fabris, P.; Rossi, G.; Invernizzi, R.; Guarnaccia, C.; Leoni, P.; Lauria, F.; Pagnucco, G.; Frassoldati, A.; Damasio, E.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - STAMPA. - 14:(1994), pp. 457-464. [10.3109/10428199409049704]

Long term results of interferon treatment in hairy cell leukemia

FEDERICO, Massimo;
1994

Abstract

Eighty nine of 104 patients with hairy cell leukemia (HCL), enrolled between 1985 and 1987 in a multicenter prospective study on human lymphoblastoid IFN alpha-n1, were evaluable for long-term follow-up. The induction treatment, 3 MU/mq daily for a median of 5.7 months, produced a response of 93%, complete+partial response (CR+PR) = 80%, minor (MR) = 13%. Neither prior splenectomy nor pre-treatment variables were associated with the rate of response to IFN. However maintenance treatment of 3 MU/mq weekly given randomly had a slightly significant effect on failure free survival (FFS). Of the 43 patients who relapsed, 31/36 (86%) obtained a new response with IFN. No differences in FFS were recorded between first and second response. At the third induction 7/11 patients were treated again with IFN, 4/7 obtaining some response, but the FFS was significantly worse. The overall survival is still 85%. We conclude that (1) IFN should be used as chronic uninterrupted treatment for HCL, (2) reduced dosage is sufficient to prolong the disease free status and (3) continuous lymphoblastoid IFN administration seems not to be associated with the development of resistance to retreatment.
1994
14
457
464
Long term results of interferon treatment in hairy cell leukemia / Capnist, G.; Federico, Massimo; Chisesi, T.; Resegotti, L.; Lamparelli, T.; Fabris, P.; Rossi, G.; Invernizzi, R.; Guarnaccia, C.; Leoni, P.; Lauria, F.; Pagnucco, G.; Frassoldati, A.; Damasio, E.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - STAMPA. - 14:(1994), pp. 457-464. [10.3109/10428199409049704]
Capnist, G.; Federico, Massimo; Chisesi, T.; Resegotti, L.; Lamparelli, T.; Fabris, P.; Rossi, G.; Invernizzi, R.; Guarnaccia, C.; Leoni, P.; Lauria, F.; Pagnucco, G.; Frassoldati, A.; Damasio, E.
File in questo prodotto:
File Dimensione Formato  
Long term results of......pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 610.76 kB
Formato Adobe PDF
610.76 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/626286
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 13
social impact